Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
In the final chapter of our pulmonary fibrosis webinar series, Dr Saad Ashraf discussed FDA-approved nerandomilast and what its introduction means for clinicians, payers, and patients living with interstitial lung disease.
In the final chapter of our pulmonary fibrosis webinar series, Dr Saad Ashraf discussed FDA-approved nerandomilast and what its introduction means for clinicians, payers, and patients living with interstitial lung disease.
Karen Iapoce explains how integrating social determinants of health into managed care workflows can drive measurable improvements in outcomes and Stars performance.
Karen Iapoce explains how integrating social determinants of health into managed care workflows can drive measurable improvements in outcomes and Stars performance.
Discover how the Inflation Reduction Act (IRA) is transforming drug value assessment as Ashis Das, MD, PhD, breaks down what the Centers for Medicare & Medicaid Services (CMS) expects from manufacturers in today’s Medicare landscape.
Discover how the Inflation Reduction Act (IRA) is transforming drug value assessment as Ashis Das, MD, PhD, breaks down what the Centers for Medicare & Medicaid Services (CMS) expects from manufacturers in today’s Medicare landscape.
Jeff Brandes discusses the national impact of Medicaid cuts, the administrative challenges forcing eligible patients off coverage, and the mounting strain on safety-net clinics.
Jeff Brandes discusses the national impact of Medicaid cuts, the administrative challenges forcing eligible patients off coverage, and the mounting strain on safety-net clinics.
Michael Hoxter, Chief Technology Officer at Lightbeam Health Solutions, discusses how advanced analytics, artificial intelligence (AI), and social determinants of health data are transforming population health management, driving efficiency,...
Michael Hoxter, Chief Technology Officer at Lightbeam Health Solutions, discusses how advanced analytics, artificial intelligence (AI), and social determinants of health data are transforming population health management, driving efficiency,...
Cotiviti’s Marge Ciancetta highlights how mid-sized Medicare Advantage plans leverage local insight, operational agility, and innovation to outperform larger national competitors.
Cotiviti’s Marge Ciancetta highlights how mid-sized Medicare Advantage plans leverage local insight, operational agility, and innovation to outperform larger national competitors.
A guest expert explores how artificial intelligence is emerging as a clinical co-pilot by streamlining administrative burdens, enhancing patient targeting and engagement, and supporting predictive care strategies to improve quality, reduce...
A guest expert explores how artificial intelligence is emerging as a clinical co-pilot by streamlining administrative burdens, enhancing patient targeting and engagement, and supporting predictive care strategies to improve quality, reduce...
Adam Colborn, JD, associate vice president for congressional affairs at the Academy of Managed Care Pharmacy, discusses how the Trump administration’s “most favored nation” drug-pricing agreements test the limits of executive authority,...
Adam Colborn, JD, associate vice president for congressional affairs at the Academy of Managed Care Pharmacy, discusses how the Trump administration’s “most favored nation” drug-pricing agreements test the limits of executive authority,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Elizabeth Volkmann, MD, MS; Carole Tremonti, RN, MBA
As new therapies for idiopathic pulmonary fibrosis (IPF) emerge, healthcare stakeholders must navigate the balance between innovation and evidence-based coverage decisions. This webinar brings together clinical, regulatory, and payer...
As new therapies for idiopathic pulmonary fibrosis (IPF) emerge, healthcare stakeholders must navigate the balance between innovation and evidence-based coverage decisions. This webinar brings together clinical, regulatory, and payer...
As new therapies for idiopathic...
11/07/2025
First Report Managed Care
Asembia is an industry leader in the specialty pharmacy sector. It aims to connect and strengthen the pharmaceutical industry and transform its ideas into significant innovations, all dedicated to optimizing and improving patients' experiences worldwide. Visit asembia.com for more information.